d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients. (Q45711274)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Patrizio Pasqualetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Emanuele Cassetta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

P M Rossini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Moffa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Cortesi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A Colloca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

L Rossi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A Finazzi-Agró

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Investigation

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

51-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11851727%20AND%20SRC:MED&resulttype=core&format=json

Oxidative stress in some dementia types

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Copper, iron and zinc in Alzheimer's disease senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Free radical damage, iron, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Reactive oxygen species and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Development and validation of a geriatric depression screening scale: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

D-penicillamine induced polymyositis causing complete heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Redox metals and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Peripheral markers of oxidative stress in probable Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Lipid peroxidation and free radical scavengers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Mounting evidence for the involvement of zinc and copper in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Intramuscular desferrioxamine in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Practical recommendations and new therapies for Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X

Total Hydroperoxide and Advanced Oxidation Protein Products in Preterm Hypoxic Babies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00933.X